These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 25818291

  • 21. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.
    Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, Carver B, Liu XS, Taulli R, Kuo WP, Nardella C, Signoretti S, Cordon-Cardo C, Gerald WL, Pandolfi PP.
    Nat Genet; 2013 Jul; 45(7):739-746. PubMed ID: 23727861
    [Abstract] [Full Text] [Related]

  • 22. β-catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma.
    Francis JC, Thomsen MK, Taketo MM, Swain A.
    PLoS Genet; 2013 Jul; 9(1):e1003180. PubMed ID: 23300485
    [Abstract] [Full Text] [Related]

  • 23. TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss.
    Pietrzak K, Kuzyakiv R, Simon R, Bolis M, Bär D, Aprigliano R, Theurillat JP, Sauter G, Santoro R.
    Proc Natl Acad Sci U S A; 2020 Feb 18; 117(7):3637-3647. PubMed ID: 32024754
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.
    Adv Enzyme Regul; 2006 Feb 18; 46():249-79. PubMed ID: 16854453
    [Abstract] [Full Text] [Related]

  • 29. Deficiency of ERβ and prostate tumorigenesis in FGF8b transgenic mice.
    Elo T, Yu L, Valve E, Mäkelä S, Härkönen P.
    Endocr Relat Cancer; 2014 Aug 18; 21(4):677-90. PubMed ID: 24938408
    [Abstract] [Full Text] [Related]

  • 30. Estrogen receptor β: switching to a new partner and escaping from estrogen.
    Leung YK, Ho SM.
    Sci Signal; 2011 Apr 12; 4(168):pe19. PubMed ID: 21487104
    [Abstract] [Full Text] [Related]

  • 31. NOTCH and PTEN in prostate cancer.
    Bertrand FE, McCubrey JA, Angus CW, Nutter JM, Sigounas G.
    Adv Biol Regul; 2014 Sep 12; 56():51-65. PubMed ID: 24933481
    [Abstract] [Full Text] [Related]

  • 32. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
    Barber AG, Castillo-Martin M, Bonal DM, Jia AJ, Rybicki BA, Christiano AM, Cordon-Cardo C.
    Cancer Med; 2015 Aug 12; 4(8):1258-71. PubMed ID: 26033689
    [Abstract] [Full Text] [Related]

  • 33. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC.
    Prostate; 2008 Feb 01; 68(2):210-22. PubMed ID: 18092350
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S.
    Carcinogenesis; 2009 May 01; 30(5):841-50. PubMed ID: 19126643
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 17β-Estradiol regulates oxidative stress in prostate cancer cell lines according to ERalpha/ERbeta ratio.
    Miró AM, Sastre-Serra J, Pons DG, Valle A, Roca P, Oliver J.
    J Steroid Biochem Mol Biol; 2011 Feb 01; 123(3-5):133-9. PubMed ID: 21172438
    [Abstract] [Full Text] [Related]

  • 39. Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice.
    Lu TL, Huang YF, You LR, Chao NC, Su FY, Chang JL, Chen CM.
    Am J Pathol; 2013 Mar 01; 182(3):975-91. PubMed ID: 23313138
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.